239 related articles for article (PubMed ID: 24346155)
1. High-dose atorvastatin reloading before percutaneous coronary intervention increased circulating endothelial progenitor cells and reduced inflammatory cytokine expression during the perioperative period.
Ye H; He F; Fei X; Lou Y; Wang S; Yang R; Hu Y; Chen X
J Cardiovasc Pharmacol Ther; 2014 May; 19(3):290-5. PubMed ID: 24346155
[TBL] [Abstract][Full Text] [Related]
2. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
[TBL] [Abstract][Full Text] [Related]
3. Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells After Percutaneous Coronary Intervention (HIPOCRATES Study).
Eisen A; Leshem-Lev D; Yavin H; Orvin K; Mager A; Rechavia E; Bental T; Dadush O; Battler A; Kornowski R; Lev EI
Cardiovasc Drugs Ther; 2015 Apr; 29(2):129-35. PubMed ID: 25712416
[TBL] [Abstract][Full Text] [Related]
4. Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study.
Zemánek D; Branny M; Martinkovičová L; Hájek P; Malý M; Tesař D; Tomašov P; Veselka J
Int J Cardiol; 2013 Oct; 168(3):2494-7. PubMed ID: 23597577
[TBL] [Abstract][Full Text] [Related]
5. Effect of intensive atorvastatin therapy on periprocedural PDCD4 expression in CD4+ T lymphocytes of patients with unstable angina undergoing percutaneous coronary intervention.
Su Q; Li L; Liu Y; Zhou Y; Wang J; Sun Y
Cardiology; 2014; 127(3):169-75. PubMed ID: 24434439
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
[TBL] [Abstract][Full Text] [Related]
7. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
[TBL] [Abstract][Full Text] [Related]
8. Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial infarction?
Nafasi L; Rahmani R; Shafiee A; Salari A; Abdollahi A; Meysamie A
Curr Med Res Opin; 2014 Mar; 30(3):381-6. PubMed ID: 23952289
[TBL] [Abstract][Full Text] [Related]
9. Impact of intensive statin use on the level of inflammation and platelet activation in stable angina after percutaneous coronary intervention: a clinical study.
Li Q; Deng SB; Xia S; Du JL; She Q
Med Clin (Barc); 2013 Jun; 140(12):532-6. PubMed ID: 23177313
[TBL] [Abstract][Full Text] [Related]
10. Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial.
Leone AM; Rutella S; Giannico MB; Perfetti M; Zaccone V; Brugaletta S; Garramone B; Niccoli G; Porto I; Liuzzo G; Biasucci LM; Bellesi S; Galiuto L; Leone G; Rebuzzi AG; Crea F
Int J Cardiol; 2008 Nov; 130(3):457-62. PubMed ID: 18667247
[TBL] [Abstract][Full Text] [Related]
11. Effect of High-Dose Atorvastatin Reload on the Release of Endothelial Progenitor Cells in Patients on Long-Term Statin Treatment Who Underwent Percutaneous Coronary Intervention (from the ARMYDA-EPC Study).
Ricottini E; Madonna R; Grieco D; Zoccoli A; Stampachiacchiere B; Patti G; Tonini G; De Caterina R; Di Sciascio G
Am J Cardiol; 2016 Jan; 117(2):165-71. PubMed ID: 26743348
[TBL] [Abstract][Full Text] [Related]
12. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.
Patti G; Chello M; Pasceri V; Colonna D; Nusca A; Miglionico M; D'Ambrosio A; Covino E; Di Sciascio G
J Am Coll Cardiol; 2006 Oct; 48(8):1560-6. PubMed ID: 17045888
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
[TBL] [Abstract][Full Text] [Related]
14. Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study.
Liu HL; Yang Y; Yang SL; Luo JP; Li H; Jing LM; Shen ZQ
Clin Ther; 2013 Mar; 35(3):261-72. PubMed ID: 23410871
[TBL] [Abstract][Full Text] [Related]
15. Effects of ezetimibe on endothelial progenitor cells and microparticles in high-risk patients.
Lins LC; França CN; Fonseca FA; Barbosa SP; Matos LN; Aguirre AC; Bianco HT; do Amaral JB; Izar MC
Cell Biochem Biophys; 2014 Sep; 70(1):687-96. PubMed ID: 24777811
[TBL] [Abstract][Full Text] [Related]
16. Effects of atorvastatin combined with trimetazidine on myocardial injury and inflammatory mediator in unstable angina patients during perioperative of percutaneous coronary intervention.
Hao J; Du H; Li WW; Zhao ZF; Liu F; Lu JC; Yang XC; Cui W
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4642-6. PubMed ID: 26698263
[TBL] [Abstract][Full Text] [Related]
17. Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial.
Baran Ç; Durdu S; Dalva K; Zaim Ç; Dogan A; Ocakoglu G; Gürman G; Arslan Ö; Akar AR
Stem Cell Rev Rep; 2012 Sep; 8(3):963-71. PubMed ID: 22076751
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.
Di Sciascio G; Patti G; Pasceri V; Gaspardone A; Colonna G; Montinaro A
J Am Coll Cardiol; 2009 Aug; 54(6):558-65. PubMed ID: 19643320
[TBL] [Abstract][Full Text] [Related]
19. [Effect of different doses of atorvastatin on adhesion molecules of the patients undergoing percutaneous coronary intervention].
Ma QL; Mo L; Yang TL; Pu XQ; Wu SB; Xie W; Zeng XL; Chen F; Chen FP
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 31(6):914-6. PubMed ID: 17213596
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients.
Oikonomou E; Siasos G; Zaromitidou M; Hatzis G; Mourouzis K; Chrysohoou C; Zisimos K; Mazaris S; Tourikis P; Athanasiou D; Stefanadis C; Papavassiliou AG; Tousoulis D
Atherosclerosis; 2015 Feb; 238(2):159-64. PubMed ID: 25525743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
